Treatment of patients with early and advanced Parkinson's disease with transdermal rotigotine: age relationship to safety and tolerability

被引：0
|
作者：
Oertel, W. [1 ]
LeWitt, P. [2 ]
Grieger, F. [3 ]
Bauer, L. [4 ]
Boroojerdi, B. [3 ]
机构：
[1] Univ Marburg, Marburg, Germany
[2] Henry Ford Hosp, Southfield, MI USA
[3] Schwarz Biosci, Monheim, Germany
[4] UCB Pharma SA NV, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2009年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：532 / 532
页数：1
相关论文
共 50 条
  • [1] Treatment of patients with early and advanced Parkinson's disease with rotigotine transdermal system: Age-relationship to safety and tolerability
    Oertel, Wolfgang
    LeWitt, Peter
    Giladi, Nir
    Ghys, Liesbet
    Grieger, Frank
    Boroojerdi, Babak
    [J]. PARKINSONISM & RELATED DISORDERS, 2013, 19 (01) : 37 - 42
  • [2] Treatment of patients with early and advanced Parkinson's disease with transdermal rotigotine: safety and tolerability in elderly patients
    Oertel, W.
    LeWitt, P.
    Watts, R.
    Grieger, F.
    Bauer, L.
    Boroojerdi, B.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S129 - S129
  • [3] Safety and tolerability of transdermal rotigotine in early stage Parkinson's disease
    Watts, Ray L.
    Patton, James M.
    Poewe, Werner
    Boroojerdi, Babak
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S82 - S82
  • [4] Long-Term Safety and Tolerability of Transdermal Rotigotine in Patients with Advanced Parkinson's Disease
    Poewe, Werner
    Rascol, Olivier
    Quinn, Niall
    Tolosa, Eduardo
    Oertel, Wolfgang
    Giladi, Nir
    Boroojerdi, Babak
    [J]. NEUROLOGY, 2009, 72 (11) : A321 - A321
  • [5] Safety and tolerability of transdermal rotigotine in early-stage Parkinson's disease
    Tagliati, M.
    Watts, R. L.
    Patton, J. M.
    Poewe, W.
    Boroojerdi, B.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S563 - S563
  • [6] Safety and tolerability of transdermal rotigotine in early-stage Parkinson's disease
    Tagliati, M.
    Watts, R. L.
    Patton, J.
    Poewe, W.
    Boroojerdi, B.
    [J]. MOVEMENT DISORDERS, 2006, 21 (09) : 1551 - 1551
  • [7] Long-term safety and tolerability of transdermal rotigotine in advanced Parkinson's disease
    Poewe, W.
    Rascol, O.
    Quinn, N.
    Tolosa, E.
    Oeriel, W. H.
    Giladi, N.
    Boroojerdi, B.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S197 - S197
  • [8] Safety and tolerability of rotigotine transdermal system in patients over 70 years with advanced Parkinson's disease
    Capecci, M.
    Andrenelli, E.
    Sordoni, E.
    Monsu, A. M.
    Di Biagio, L.
    Ceravolo, M. G.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S136 - S136
  • [9] Safety and tolerability of rotigotine in advanced Parkinson's disease
    LeWitt, Peter A.
    Lyons, Kelly E.
    Pahwa, Rajesh
    Poewe, Werner
    Rascol, Olivier
    Quinn, Niall
    Tolosa, Eduardo
    Oertel, Wolfgang M.
    Boroojerdi, Babak
    [J]. ANNALS OF NEUROLOGY, 2008, 64 : S54 - S55
  • [10] Rotigotine transdermal system in treatment of patients with advanced-stage Parkinson's disease
    LeWitt, P. A.
    Chang, F-L.
    Fazzini, E.
    Nausieda, P. A.
    Daniel, T.
    Boroojerdi, B.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 15 - 16
12345